IL-6 AND VEGF IN SMALL CELL LUNG CANCER PATIENTS

被引：0
|
作者：
Kulpa, J. K. [1 ]
Wojcik, E. [1 ]
Skotnicki, P. [1 ]
Tarapacz, J. [1 ]
机构：
[1] M Sklodowska Curie Mem Inst, Cracow Div, Ctr Oncol, Dept Clin Biochem, Krakow, Poland
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 6B期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：4075 / 4075
页数：1
相关论文
共 50 条
  • [41] Clinical Implications of VEGF, TGF-β1, and IL-1β in Patients with Advanced Non-small Cell Lung Cancer
    Kim, Ji-Won
    Koh, Youngil
    Kim, Dong-Wan
    Ahn, Yong-Oon
    Kim, Tae Min
    Han, Sae-Won
    Oh, Do-Youn
    Lee, Se-Hoon
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2013, 45 (04): : 325 - 333
  • [42] Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-α, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients
    Krzystek-Korpacka, Malgorzata
    Matusiewicz, Malgorzata
    Diakowska, Dorota
    Grabowski, Krzysztof
    Blachut, Katarzyna
    Kustrzeba-Wojcicka, Irena
    Banas, Teresa
    CLINICAL BIOCHEMISTRY, 2007, 40 (18) : 1353 - 1360
  • [43] The relationship between the systemic inflammatory response and VEGF, VEGF-C, IL-6 and IL-10 in patients undergoing potentially curative resection for colorectal cancer
    Breckenridge, F.
    Wallace, A. M.
    Crozier, J. E. M.
    Leitch, E. F.
    McKee, R. F.
    McMillan, D. C.
    SCOTTISH MEDICAL JOURNAL, 2008, 53 (01) : 55 - 56
  • [44] Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors
    Ebrahem, Quteba
    Minamoto, Atsushi
    Hoppe, George
    Anand-Apte, Bela
    Sears, Jonathan E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (11) : 4935 - 4941
  • [45] VEGF and IL-18 in induced sputum of lung cancer patients
    Rovina, Nikoletta
    Hillas, Georgios
    Dima, Efrossini
    Vlastos, Fotis
    Loukides, Stylianos
    Veldekis, Dimitrios
    Roussos, Charis
    Alhanatis, Manos
    Bakakos, Petros
    CYTOKINE, 2011, 54 (03) : 277 - 281
  • [46] IL-6 AND IL-6 RECEPTOR
    MURAKAMI, M
    HIRANO, T
    SEIKAGAKU, 1990, 62 (01): : 32 - 35
  • [47] Evaluation of clinical usefulness of VEGF, IL-1a and IL-6 as a tumor marker for cervical cancer.
    Park, WH
    Lee, MJ
    Lee, KO
    CLINICAL CHEMISTRY, 2000, 46 (06) : A158 - A158
  • [48] Review: The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)
    Ke, Wanhai
    Zhang, Li
    Dai, Yan
    THORACIC CANCER, 2020, 11 (04) : 835 - 839
  • [49] IL-6 promotes growth and epithelial-mesenchymal transition of CD133+cells of non-small cell lung cancer
    Lee, Soo Ok
    Yang, Xiaodong
    Duan, Shanzhou
    Tsai, Ying
    Strojny, Laura R.
    Keng, Peter
    Chen, Yuhchyau
    ONCOTARGET, 2016, 7 (06) : 6626 - 6638
  • [50] IL-37 mediates the anti-tumor activity in non-small cell lung cancer through IL-6/STAT3 pathway
    Deng, Yan-Ming
    Zhang, Hua
    Liang, Jian-Miao
    Xian, Hai-Bing
    Chen, Ze-Cheng
    Tang, Yi-Cong
    Yang, Shuang
    Feng, Wei-Neng
    JOURNAL OF APPLIED BIOMEDICINE, 2018, 16 (01) : 15 - 21
12345